VADUZ, Liechtenstein, May 9, 2025 /PRNewswire/ — Global expansion of RefluxStop™ Significant events in the first quarter of 2025 Received positive feedback from U.S. FDA on our Clinical Module 2 Premarket Approval (PMA) application. FDA accepted Module 1 containing the quality systems…
